Connor-Davidson Resilience scale (CD-RISC; scored 0-40, higher scores indicate greater resilience)

Post-Traumatic Growth Inventory (PTGI; scored 0-105 with factor subscales ranging from 0-10 to 0-35; higher scores indicate more positive transformation). Sub-scores are summed together to receive the overall score.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Personal Strength sub-scale is scored from 0-20 with higher scores indicating increased resilience, self-reliance, confidence, humility, etc.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory New Possibilities sub-scale is scored from 0-25 with higher scores indicating an increase in new interests, perspectives, more adaptability and openness to new opportunities.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Improved Relationship sub-scale is scored from 0-35 with higher scores indicating an increased sense of belonging, emotional vulnerability, empathy, more supportive, and have an increased ability to form stronger bonds with others.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Spiritual Growth sub-scale is scored from 0-10 with higher scores indicating deeper and more meaningful beliefs, life philosophies and faith, more awareness, and a clearer purpose in life.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Appreciation for Life sub-scale is scored from 0-15 with higher scores indicating increased gratitude, appreciation for the positive things in life, and clearer sense of priorities.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with each factor scored 0-16, higher scores indicate greater spiritual well-being). The overall score is a summation of each sub-score.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with higher scores indicate greater spiritual well-being). The Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Meaning sub-scale is scored from 0-16 with one question reverse coded. Item scores for the sub-scale are summed, multiplied by 4, and divided by the number of items answered by the participant. A higher score indicates a greater sense of a meaningful life.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with higher scores indicate greater spiritual well-being). The Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Peace sub-scale is scored from 0-16 with one question reverse coded. Item scores for the sub-scale are summed, multiplied by 4, and divided by the number of items answered by the participant. A higher score indicates a greater sense of inner peace or harmony.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with higher scores indicate greater spiritual well-being). The Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Faith sub-scale is scored from 0-16. Item scores for the sub-scale are summed, multiplied by 4, and divided by the number of items answered by the participant. A higher score indicates a greater sense of faith and spiritual beliefs.

Patient Activation Measure (PAM; scored 0-100, higher scores indicate greater activation)

Fear of Cancer Recurrence Inventory (FCRI-SF; scored 0-36, higher scores indicate greater fear of cancer recurrence)

Patient Health Questionnaire (PHQ-8; scored 0-24, higher scores indicate worse depressive symptoms)

General Anxiety Disorder Anxiety Scale (GAD-7; scored 0-21, higher scores indicate worse anxiety)

Patient-Reported Outcomes Measurement Information System Global Health - Physical Health (PROMIS-Global; physical health scored 4-20 with T-scores ranging from 16.2-67.7 and standard errors ranging from 4.8-5.9). A T-score of 50 represents the mean for the general population with a standard deviation of 10. A higher T-score indicates better physical health. A lower T-score would indicate a decrease in physical health.

Patient-Reported Outcomes Measurement Information System Global Health - Mental Health (PROMIS-Global; mental health scored 4-20 with T-scores ranging from 21.2-67.6 and standard errors ranging from 4.6-5.3). A T-score of 50 represents the mean for the general population with a standard deviation of 10. A higher T-score indicates better mental health. A lower T-score would indicate a decrease in mental health.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

One point was assigned if BMI>30, systolic (SBP)>140 mmHg or diastolic blood pressure (DBP)>90 abstracted from the closest clinical encounter to the baseline visit, high-sensitivity C-reactive protein >0.41 mg/dL, HgbA1c>5.4, albumin<4 gm/dL and/or creatinine clearance <59 ml/min, total cholesterol >240 and/or triglycerides >150 mg/dL. The score range for this measure ranged from 0-9 with higher scores indicating a higher burden of stress or strain on the patient's body that can lead to worse outcomes.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Highest level of education obtained at the start of the intervention

Employment status at the start of the intervention

Insurance coverage at the start of the intervention

Rurality is derived from Rural-Urban Commuting Area (RUCA) codes created using the participant's place of residence

More deprived neighborhoods are link to worse health outcomes when compared to those in neighborhoods that are less deprived. Index is based on the participant's place of residence.

Cancer stage was captured from the participant's electronic medical record which utilizes the American Joint Committee on Cancer (AJCC) TNM system. The TNM system take into account tumor size, if cancer has spread to lymph nodes, and metastasis to distant organs. Stage numbers often represent the degree to which cancer has spread. A lower stage number indicates a more early-stage cancer that generally has a good prognosis. As the stage number increases, the cancer becomes more advanced and more difficult to treat.

HR is hormone receptor and can be positive or negative. HR+ indicates that tumor cells have receptors for estrogen and progesterone that promotes tumor growth. HR- indicates that tumor cells do not have hormone receptors. HER2 is human epidermal growth factor receptor 2 and can be positive of negative. HER2+ indicates that tumor cells have higher levels of HER2/neu and is associate with more aggressive breast cancers.

Only females were recruited.

Acceptability, appropriateness, and feasibility of the intervention were measured using the Acceptability of Intervention Measure (AIM; scored 1-5), Intervention Appropriateness Measure (IAM; scored 1-5), and Feasibility of Intervention Measure (FIM; scored 1-5). Higher scores indicated better outcomes for each validated survey tool. If means are greater than 4, then the study is considered acceptable, appropriate, and/or feasible.

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Connor-Davidson Resilience scale (CD-RISC; scored 0-40, higher scores indicate greater resilience)

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Post-Traumatic Growth Inventory (PTGI; scored 0-105 with factor subscales ranging from 0-10 to 0-35; higher scores indicate more positive transformation). Sub-scores are summed together to receive the overall score.

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Personal Strength sub-scale is scored from 0-20 with higher scores indicating increased resilience, self-reliance, confidence, humility, etc.

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory New Possibilities sub-scale is scored from 0-25 with higher scores indicating an increase in new interests, perspectives, more adaptability and openness to new opportunities.

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Improved Relationship sub-scale is scored from 0-35 with higher scores indicating an increased sense of belonging, emotional vulnerability, empathy, more supportive, and have an increased ability to form stronger bonds with others.

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Spiritual Growth sub-scale is scored from 0-10 with higher scores indicating deeper and more meaningful beliefs, life philosophies and faith, more awareness, and a clearer purpose in life.

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Post-Traumatic Growth Inventory (PTGI; scored 0-105; higher scores indicate more positive transformation). The Post-Traumatic Growth Inventory Appreciation for Life sub-scale is scored from 0-15 with higher scores indicating increased gratitude, appreciation for the positive things in life, and clearer sense of priorities.

Out of 43 participants, only 33 completed both surveys to obtain a pre/post value for each measure.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with each factor scored 0-16, higher scores indicate greater spiritual well-being). The overall score is a summation of each sub-score.

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with higher scores indicate greater spiritual well-being). The Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Meaning sub-scale is scored from 0-16 with one question reverse coded. Item scores for the sub-scale are summed, multiplied by 4, and divided by the number of items answered by the participant. A higher score indicates a greater sense of a meaningful life.

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with higher scores indicate greater spiritual well-being). The Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Peace sub-scale is scored from 0-16 with one question reverse coded. Item scores for the sub-scale are summed, multiplied by 4, and divided by the number of items answered by the participant. A higher score indicates a greater sense of inner peace or harmony.

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Functional Assessment of Chronic Illness Therapy Spiritual Well-Being tool (FACIT-Sp; scored 0-48 with higher scores indicate greater spiritual well-being). The Functional Assessment of Chronic Illness Therapy Spiritual Well-Being Faith sub-scale is scored from 0-16. Item scores for the sub-scale are summed, multiplied by 4, and divided by the number of items answered by the participant. A higher score indicates a greater sense of faith and spiritual beliefs.

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Patient Activation Measure (PAM; scored 0-100, higher scores indicate greater activation)

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Fear of Cancer Recurrence Inventory (FCRI-SF; scored 0-36, higher scores indicate greater fear of cancer recurrence)

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Patient Health Questionnaire (PHQ-8; scored 0-24, higher scores indicate worse depressive symptoms)

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

General Anxiety Disorder Anxiety Scale (GAD-7; scored 0-21, higher scores indicate worse anxiety)

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Patient-Reported Outcomes Measurement Information System Global Health - Physical Health (PROMIS-Global; physical health scored 4-20 with T-scores ranging from 16.2-67.7 and standard errors ranging from 4.8-5.9). A T-score of 50 represents the mean for the general population with a standard deviation of 10. A higher T-score indicates better physical health. A lower T-score would indicate a decrease in physical health.

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Patient-Reported Outcomes Measurement Information System Global Health - Mental Health (PROMIS-Global; mental health scored 4-20 with T-scores ranging from 21.2-67.6 and standard errors ranging from 4.6-5.3). A T-score of 50 represents the mean for the general population with a standard deviation of 10. A higher T-score indicates better mental health. A lower T-score would indicate a decrease in mental health.

Of 43 participants, 33 completed both surveys to obtain a pre/post value for each measure.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.

Biomarker samples were taken prior to and approximately one month after the last PRISM intervention session.

Biomarkers were only collected on participants with early-stage breast cancer (n=32). Of the 32 participants, 25 completed both surveys, biomarker collection timepoints, and all PRISM sessions.